AstraZeneca Pharma India Stock (NSE:ASTRAZEN)

INDIA |NSE |INR

Price
INR 2,804.70
Change
-0.94%
Today's Range
INR2,800.00 - INR2,861.95
52-Week Range
INR2,525.95 - INR4,357.20
Market Cap
INR68.74B
Volume
9.24K

About Astrazeneca Pharma India (NSE:ASTRAZEN)

(NSE:ASTRAZEN) AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and distributes pharmaceutical products in India and internationally. It manufactures and sells medicines under the Brilinta, Axcer, Forxiga, Oxra, Gledepa, Xigduo, Symbicort, Onglyza, Kombiglyze, Tagrisso, Lynparza, Zoladex, QTERN, and Imfinzi brand names. The company offers products in the areas of cardiovascular, renal, metabolic, oncology, antidiabetic, respiratory, inflammation, and autoimmunity diseases. It also provides clinical trial services. The company was founded in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Show more

ASTRAZEN Stock Price

Statistics Highlights (NSE:ASTRAZEN)

Shares Outstanding 25.00M Beta 0.49
Public Float 4.42M P/E Ratio 112.92
% Short of Float - Dividend (Yield) 2.00 (0.00%)
Held by Insiders 84.70% Ex-Dividend Date Aug 18, 2021
Held by Institutions 2.92% IPO Date -

ASTRAZEN Financial Summary

|
Mar 21 Mar 20 Mar 19
Revenue INR8.09B INR8.32B INR7.28B
EBITDA INR1.48B INR1.34B INR875.90M
Net Income INR933.00M INR722.10M INR544.50M
Total Assets INR7.75B INR7.06B INR5.62B
Total Cash INR3.52B INR835.00M INR1.73B
Total Debt INR121.40M INR118.40M INR
Sep 21 Jun 21 Mar 21
Revenue INR1.98B INR1.75B INR2.05B
EBITDA INR207.60M INR185.31M INR425.70M
Net Income INR119.47M INR102.43M INR272.75M
Total Assets INR8.14B INR INR7.75B
Total Cash INR3.97B INR INR3.52B
Total Debt INR104.36M INR INR121.40M

ASTRAZEN Stock Price History

Astrazeneca Pharma India Annual Stock Price History

Year Open Close Change
2021 INR3024.95 INR2804.70 -7.28%
2021 INR4639.00 INR3024.95 -34.79%
2020 INR2699.85 INR4639.00 71.82%

Astrazeneca Pharma India Daily Stock Price History

Date Open High Low Close Change Volume
Jun 27, 2022 INR2735.10 INR2820.05 INR2705.75 INR2729.10 -7.38% 8.30K
Jun 8, 2022 INR2910.00 INR2955.00 INR2909.00 INR2946.55 3.12% 5.98K
Jun 14, 2022 INR2806.20 INR2879.80 INR2806.20 INR2857.40 6.64% 3.75K

(NSE:ASTRAZEN) Stock Price FAQs

What is today's stock price of Astrazeneca Pharma India (NSE:ASTRAZEN)?

  • The current stock price of Astrazeneca Pharma India (NSE:ASTRAZEN) is INR2804.70.
  • Today ASTRAZEN stock price opened at INR2835.60 after previous close of INR2831.25.
  • During the day, Astrazeneca Pharma India stock quote has varied from a low of INR2800.00 to a high of INR2861.95.

What is Astrazeneca Pharma India's 52-week change?

  • ASTRAZEN 52-week high stock quote is INR4357.20, which is 55.40% above the current share price.
  • The Astrazeneca Pharma India (NSE:ASTRAZEN) 52-week low stock price is INR2525.95, which is 9.90% below the current share price.
  • Astrazeneca Pharma India share price volatility (52-week beta) is 0.49.

Astrazeneca Pharma India (NSE:ASTRAZEN) FAQ

How Much is Astrazeneca pharma india Worth?

Astrazeneca pharma india's worth today based on market capitalisation is INR68.74B

How much dividend does Astrazeneca pharma india Pay?

The current annualized dividend payout for ASTRAZEN stock is INR4.00, the dividend yield is 0.14% and the payout ratio is 8.22%.
View More Details on Astrazeneca pharma india's "Dividend" Section

What is Astrazeneca pharma india’s Price to Earning (PE) ratio?

Astrazeneca pharma india has a Price to Earning (P/E) ratio of 112.92. ASTRAZEN stock also has a Price to Sales (P/S) ratio of 8.77.

What is the Astrazeneca pharma india's ticker?

Astrazeneca pharma india trades on the NSE stock market in India under the ticker symbol "ASTRAZEN". Astrazeneca pharma india’s stock symbol can also be displayed as "NSE:ASTRAZEN".

Who are the owners of Astrazeneca pharma india?

Astrazeneca pharma india (NSE:ASTRAZEN) is owned by 2.92% institutional shareholders and by 84.70% insiders. The rest is owned by the public.
Explore More Details on Astrazeneca pharma india's “Ownership” Section

Who are the key executives of Astrazeneca pharma india (ASTRAZEN)?

Astrazeneca pharma india's key executive team includes the following managers:

  • Mr. Gagandeep Singh Bedi, MD, Country Pres & Exec. Director (1971)
  • Mr. Rajesh Marwaha, CFO & Exec. Director (1963)
  • Mr. Pratap Rudra Bhuvanagiri, Company Sec., Legal Counsel & Compliance Officer (NA)
  • Ms. Smita Saha, VP of HR (1970)
  • Mr. Richard Cheeseman, Head of Engineering & Facilities (1973)
  • Mr. Vimlesh Maheshwari, Fin. Controller (NA)
  • Dr. K. R. Premnath Shenoy, Director of Regulatory (1956)
  • Mr. Ramesh Kadaba Venkatapathi, Director of Quality Assurance & Technical Services (1952)
  • Dr. Paurus Mehelli Irani, Global Medical Affairs Leader - Infection (1967)
  • Mr. Rajeev Nagi, VP of Institutions & International Bus. (1970)

What is Astrazeneca pharma india’s Sector & Industry Classification?

Astrazeneca pharma india (NSE:ASTRAZEN) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Astrazeneca pharma india?

Currently the number of employees working for Astrazeneca pharma india is 1,283.

Where are Astrazeneca pharma india's Headquarters?

Astrazeneca pharma india (NSE:ASTRAZEN) is headquartered in India.

What are Astrazeneca pharma india's Address and Phone Number?

Astrazeneca pharma india’s mailing address is Manyata Embassy Business Park, Bengaluru, India, 560045.
The company’s phone number is 91 80 6774 8000.

What is the official website for Astrazeneca pharma india?

Astrazeneca pharma india’s official website is http://www.astrazeneca.com/india